Photo from Alfredo Rivas-Delgado/X
Apr 29, 2024, 00:54
Alfredo Rivas-Delgado: Review on treating high-risk MCL patients by Anita Kumar
Alfredo Rivas-Delgado, Research Fellow at Memorial Sloan Kettering Cancer, posted on X/Twitter:
“A comprehensive review on treating high-risk MCL patients by Anita Kumar
– High Ki67, TP53mut, blastoid morphology, POD24
– Targeted therapy including BTKi + BCL2inh + antiCD20
– Promising data with CAR-T and BsAbs
– Refer early to tertiary centers.“
Source: Alfredo Rivas-Delgado/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19